According to the report titled ‘Global Zika Virus Testing Market Size study, by Test Type (Rapid IgG/IgM Test, ELISA Test) by End-User (Hospitals & Clinics, Private Commercial Laboratories, Government/Publicly Funded Programs) and Regional Forecasts 2021-2027’, available with Market Study Report, global zika virus testing market is anticipated to record an annual growth rate of 2.5% during 2021-2027.
 

Government initiated information drives to raise awareness about the spread of zika virus, and advancements in healthcare vertical are primary factors behind the growth of global zika virus testing market.
 

Moreover, the COVID-19 pandemic outbreak has also driven the people to get tested for different viral strains, in turn generating the revenues for the industry.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3839583/
 

For the unversed, the zika virus is a vector borne disease exhibiting symptoms like fever, headache, nausea, fatigue etc. The existence of the virus in human body can be found out by testing body samples like urine, serum, and plasma. Several testing approaches like antigen identification, viral culture, serology, and nucleic acid detection are used in order to detect the existence of the virus and to identify its antibodies.
 

Though initiatives for regular testing of women for zika virus will present lucrative growth opportunities, but inefficiency of these to test in detecting the virus is slated to pose as challenge for the market sphere.
 

By test type, worldwide zika virus testing market is segmented into rapid IgG/IgM test, and ELISA test. On the basis of end user spectrum, the industry is divided into private commercial laboratories, hospitals & clinics, and government/publicly funded programs.
 

Moving on to regional terrain, the market dynamics in Asia Pacific, Europe, North America, and Latin America are considered to unveil profitable prospects and make investment decisions.
 

As per the report, Latin America market is expected to grow significantly through 2027, owing to rapid spread of zika virus. Similarly, the market in Asia Pacific is also slated to witness growth over the analysis timeframe, owing to increase in the population of Aedes aegypti mosquitoes that are known to be the carrier of zika virus.
 

The competitive landscape of global zika virus testing market is defined by companies such as Biocan Diagnostics Inc., RapiGEN Inc., Quest Diagnostics, GenBody Inc., JAJ International Inc., Artron Laboratories Inc., LumiQuick Diagnostics Inc., EUROIMMUN US Inc., and Nectar Lifesciences Ltd.